当前位置:首页 - 行情中心 - 天新药业(603235) - 财务分析 - 利润表

天新药业

(603235)

  

流通市值:40.21亿  总市值:119.69亿
流通股本:1.47亿   总股本:4.38亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入1,122,350,298.53618,910,665.472,208,570,173.441,613,579,810.79
  营业收入1,122,350,298.53618,910,665.472,208,570,173.441,613,579,810.79
二、营业总成本710,909,338.89371,946,946.361,474,222,808.061,058,098,256.39
  营业成本585,514,347.36310,504,139.191,280,721,611.98931,582,176.69
  税金及附加11,416,757.774,853,558.6422,726,602.4915,942,085.61
  销售费用19,847,242.958,694,796.6532,849,944.3424,631,752.99
  管理费用77,512,431.835,356,960.95144,174,525.1398,966,470.13
  研发费用42,459,796.6820,722,319.47103,818,345.3772,715,184.45
  财务费用-25,841,237.67-8,184,828.54-110,068,221.25-85,739,413.48
  其中:利息费用3,973,907.09-3,950,394.8-
  其中:利息收入17,480,303.6714,257,098.0159,361,872.31-
三、其他经营收益
  加:公允价值变动收益465,538.02-2,208,868.22,238,666.8-
  加:投资收益4,121,010.463,822,583.425,444,358.63,650,670.48
  资产处置收益-10,296.5-407.12962.33962.33
  资产减值损失(新)-14,004,087.93--7,542,795.49-5,231,148.92
  信用减值损失(新)1,044,634.2-780,792.6-3,463,779.99-1,894,901.85
  其他收益22,171,901.5812,108,734.0343,330,750.6735,733,010.74
四、营业利润425,229,659.47259,904,968.64774,355,528.3587,740,147.18
  加:营业外收入438,110.3181,612.141,060,805.2741,460.68
  减:营业外支出1,078,229.5270,860.723,643,954.342,797,593.87
五、利润总额424,589,540.26259,915,720.06771,772,379.23584,984,013.99
  减:所得税费用68,575,990.9641,348,618.32120,549,239.6290,501,036.02
六、净利润356,013,549.3218,567,101.74651,223,139.61494,482,977.97
(一)按经营持续性分类
  持续经营净利润356,013,549.3218,567,101.74651,223,139.61494,482,977.97
(二)按所有权归属分类
  归属于母公司股东的净利润356,013,549.3218,567,101.74651,223,139.61494,482,977.97
  扣除非经常损益后的净利润336,278,264.05208,976,403.83614,419,922.59467,606,534.94
七、每股收益
  (一)基本每股收益0.820.51.491.13
  (二)稀释每股收益0.820.51.491.13
九、综合收益总额356,013,549.3218,567,101.74651,223,139.61494,482,977.97
  归属于母公司股东的综合收益总额356,013,549.3218,567,101.74651,223,139.61494,482,977.97
公告日期2025-08-292025-04-302025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑